News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CombiMatrix Corporation (CBMX) and Pathology Inc. Form Partnership to Market and Distribute Prenatal Tests



11/6/2012 9:50:36 AM

IRVINE, Calif., Nov. 6, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that it has entered into a strategic partnership with Pathology, Inc. whereby Pathology, Inc. will market and distribute CombiMatrix chromosomal microarray tests for the Products of Conception (POC) testing market in designated geographic areas. The POC testing market is a subset of the overall prenatal testing market.

Read at GlobeNewswire


comments powered by Disqus
   
Pregnancy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES